{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:02:24Z","timestamp":1783695744799,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Social Welfare and Rehabilitation Science","award":["2592"],"award-info":[{"award-number":["2592"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10072-021-05815-w","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:03:06Z","timestamp":1642291386000},"page":"3847-3855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The second family affected with a PRDM8-related disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Atefeh","family":"Davarzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Shahrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Saleh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Habibi Kavashkohei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Farboodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-2475","authenticated-orcid":false,"given":"Afagh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"key":"5815_CR1","volume-title":"Progressive myoclonus epilepsy, Lafora type, GeneReviews\u00ae[Internet]","author":"AC Jansen","year":"2019","unstructured":"Jansen AC, Andermann E (2019) Progressive myoclonus epilepsy, Lafora type, GeneReviews\u00ae[Internet]. University of Washington, Seattle"},{"issue":"1","key":"5815_CR2","first-page":"e6793","volume":"12","author":"Y Al Mufargi","year":"2020","unstructured":"Al Mufargi Y, Qureshi A, Al Asmi A (2020) Lafora disease: report of a rare entity. Cureus 12(1):e6793","journal-title":"Cureus"},{"issue":"1","key":"5815_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0887-8994(00)00276-9","volume":"25","author":"BA Minassian","year":"2001","unstructured":"Minassian BA (2001) Lafora\u2019s disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 25(1):21\u201329","journal-title":"Pediatr Neurol"},{"issue":"11","key":"5815_CR4","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nn1998","volume":"10","author":"D Vilchez","year":"2007","unstructured":"Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B, Criado-Garc\u00eda O, Fernandez-Sanchez E, Medra\u00f1o-Fern\u00e1ndez I, Dom\u00ednguez J (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10(11):1407\u20131413","journal-title":"Nat Neurosci"},{"issue":"10","key":"5815_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41582-018-0057-0","volume":"14","author":"F Nitschke","year":"2018","unstructured":"Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA (2018) Lafora disease\u2014from pathogenesis to treatment strategies. Nat Rev Neurol 14(10):606\u2013617","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"5815_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41582-018-0057-0","volume":"14","author":"F Nitschke","year":"2018","unstructured":"Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BAJNRN (2018) Lafora disease\u2014from pathogenesis to treatment strategies. Nat Rev Neurol 14(10):606\u2013617","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"5815_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.1575","volume":"106","author":"A Delgado-Escueta","year":"2001","unstructured":"Delgado-Escueta A, Ganesh S, Yamakawa K (2001) Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 106(2):129\u2013138","journal-title":"Am J Med Genet"},{"key":"5815_CR8","doi-asserted-by":"publisher","first-page":"116260","DOI":"10.1016\/j.carbpol.2020.116260","volume":"240","author":"MK Brewer","year":"2020","unstructured":"Brewer MK, Putaux J-L, Rondon A, Uittenbogaard A, Sullivan MA, Gentry MS (2020) Polyglucosan body structure in Lafora disease. Carbohydr Polym 240:116260","journal-title":"Carbohydr Polym"},{"issue":"3","key":"5815_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1042\/BJ20111416","volume":"441","author":"PJ Roach","year":"2012","unstructured":"Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS (2012) Glycogen and its metabolism: some new developments and old themes. Biochem J 441(3):763\u2013787","journal-title":"Biochem J"},{"issue":"5","key":"5815_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11910-007-0066-7","volume":"7","author":"AV Delgado-Escueta","year":"2007","unstructured":"Delgado-Escueta AV (2007) Advances in lafora progressive myoclonus epilepsy. Curr Neurol Neurosci Rep 7(5):428\u2013433","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"49","key":"5815_CR11","doi-asserted-by":"publisher","first-page":"33816","DOI":"10.1074\/jbc.M807428200","volume":"283","author":"VS Tagliabracci","year":"2008","unstructured":"Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, Zhao X, Minassian BA, DePaoli-Roach AA, Roach PJ (2008) Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem 283(49):33816\u201333825","journal-title":"J Biol Chem"},{"issue":"9","key":"5815_CR12","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1093\/brain\/aws205","volume":"135","author":"J Turnbull","year":"2012","unstructured":"Turnbull J, Girard J-M, Lohi H, Chan EM, Wang P, Tiberia E, Omer S, Ahmed M, Bennett C, Chakrabarty A (2012) Early-onset Lafora body disease. Brain 135(9):2684\u20132698","journal-title":"Brain"},{"issue":"2","key":"5815_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ng1238","volume":"35","author":"EM Chan","year":"2003","unstructured":"Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M, Ackerley CA, Jovic NJJNG (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35(2):125\u2013127","journal-title":"Nat Genet"},{"issue":"4","key":"5815_CR14","doi-asserted-by":"publisher","first-page":"e1002037","DOI":"10.1371\/journal.pgen.1002037","volume":"7","author":"J Turnbull","year":"2011","unstructured":"Turnbull J, DePaoli-Roach AA, Zhao X, Cortez MA, Pencea N, Tiberia E, Piliguian M, Roach PJ, Wang P, Ackerley CA (2011) PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet 7(4):e1002037","journal-title":"PLoS Genet"},{"issue":"2","key":"5815_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","volume":"8","author":"JM Serratosa","year":"1999","unstructured":"Serratosa JM, G\u00f3mez-Garre P, Gallardo ME, Anta B, De Bernab\u00e9 DB-V, Lindhout D, Augustijn PB, Tassinari CA, Michelucci R, Malafosse AJHMG (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8(2):345\u2013352","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5815_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/01.WNL.0000133215.65836.03","volume":"63","author":"E Chan","year":"2004","unstructured":"Chan E, Omer S, Ahmed M, Bridges L, Bennett C, Scherer S, Minassian BJN (2004) Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 63(3):565\u2013567","journal-title":"Neurology"},{"issue":"11","key":"5815_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Sakamoto T, Avila MR, Machado-Salas J, Hoshii Y, Akagi T, Gomi H, Suzuki T, Amano K (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11(11):1251\u20131262","journal-title":"Hum Mol Genet"},{"issue":"7","key":"5815_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.15252\/emmm.201707608","volume":"9","author":"F Nitschke","year":"2017","unstructured":"Nitschke F, Sullivan MA, Wang P, Zhao X, Chown EE, Perri AM, Israelian L, Juana-L\u00f3pez L, Bovolenta P, Rodr\u00edguez de C\u00f3rdoba S (2017) Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. EMBO Mol Med 9(7):906\u2013917","journal-title":"EMBO Mol Med"},{"issue":"6","key":"5815_CR19","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/humu.20737","volume":"29","author":"S Singh","year":"2008","unstructured":"Singh S, Satishchandra P, Shankar SK, Ganesh S (2008) Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Hum Mutat 29(6):E1\u2013E12","journal-title":"Hum Mutat"},{"issue":"1","key":"5815_CR20","doi-asserted-by":"crossref","first-page":"2005.0003","DOI":"10.1038\/msb4100006","volume":"1","author":"J van de Peppel","year":"2005","unstructured":"van de Peppel J, Holstege FC (2005) Multifunctional genes. Mol Syst Biol 1(1):2005.0003","journal-title":"Mol Syst Biol"},{"issue":"1","key":"5815_CR21","doi-asserted-by":"publisher","first-page":"e86356","DOI":"10.1371\/journal.pone.0086356","volume":"9","author":"M Inoue","year":"2014","unstructured":"Inoue M, Kuroda T, Honda A, Komabayashi-Suzuki M, Komai T, Shinkai Y, Mizutani K-I (2014) Prdm8 regulates the morphological transition at multipolar phase during neocortical development. PLoS One 9(1):e86356","journal-title":"PLoS One"},{"issue":"23","key":"5815_CR22","doi-asserted-by":"publisher","first-page":"E3010","DOI":"10.1073\/pnas.1505870112","volume":"112","author":"CC Jung","year":"2015","unstructured":"Jung CC, Atan D, Ng D, Ploder L, Ross SE, Klein M, Birch DG, Diez E, McInnes RR (2015) Transcription factor PRDM8 is required for rod bipolar and type 2 OFF-cone bipolar cell survival and amacrine subtype identity. Proc Natl Acad Sci 112(23):E3010\u2013E3019","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"5815_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/cancers12041057","volume":"12","author":"E Orouji","year":"2020","unstructured":"Orouji E, Peitsch WK, Orouji A, Houben R, Utikal J (2020) Unique role of histone methyltransferase PRDM8 in the tumorigenesis of virus-negative Merkel cell carcinoma. Cancers 12(4):1057","journal-title":"Cancers"},{"key":"5815_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13273-019-00068-3","volume":"16","author":"J Park","year":"2020","unstructured":"Park J, Kwon SO, Kim S-H, Kim SJ, Koh EJ, Won S, Kim WJ, Hwang SY (2020) Methylation quantitative trait loci analysis in Korean exposome study. Mol Cell Toxicol 16:175\u2013183","journal-title":"Mol Cell Toxicol"},{"key":"5815_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fimmu.2019.00791","volume":"10","author":"M Neidhart","year":"2019","unstructured":"Neidhart M, Pajak A, Laskari K, Riksen NP, Joosten LA, Netea MG, Lutgens E, Stroes ES, Ciurea A, Distler O (2019) Oligomeric S100A4 is associated with monocyte innate immune memory and bypass of tolerance to subsequent stimulation with lipopolysaccharides. Front Immunol 10:791","journal-title":"Front Immunol"},{"issue":"5","key":"5815_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector EJGIM (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013423","journal-title":"Genet Med"},{"issue":"12","key":"5815_CR27","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1111\/epi.12806","volume":"55","author":"E Ferlazzo","year":"2014","unstructured":"Ferlazzo E, Canafoglia L, Michelucci R, Gambardella A, Gennaro E, Pasini E, Riguzzi P, Plasmati R, Volpi L, Labate A (2014) Mild L afora disease: clinical, neurophysiologic, and genetic findings. Epilepsia 55(12):e129\u2013e133","journal-title":"Epilepsia"},{"issue":"2","key":"5815_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuron.2011.09.035","volume":"73","author":"SE Ross","year":"2012","unstructured":"Ross SE, McCord AE, Jung C, Atan D, Mok SI, Hemberg M, Kim T-K, Salogiannis J, Hu L, Cohen SJN (2012) Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron 73(2):292\u2013303","journal-title":"Neuron"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05815-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:44:31Z","timestamp":1653018271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05815-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5815"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05815-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]},"assertion":[{"value":"6 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants, after being informed of the nature of the research, consented to participate. This research was performed in accordance with the Declaration of Helsinki and with approval of the ethics board of the University of Social Welfare and Rehabilitation Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}